Mirja Thomsen,Fabian Ott,Sebastian Loens,Gamze Kilic-Berkmen,Ai Huey Tan,Shen-Yang Lim,Ebba Lohmann,Kaja M. Schröder,Lea Ipsen,Lena A. Nothacker,Linn Welzel,Alexandra S. Rudnik,Frauke Hinrichs,Thorsten Odorfer,Kirsten E. Zeuner,Friederike Schumann,Andrea A. Kühn,Simone Zittel,Marius Moeller,Robert Pfister,Christoph Kamm,Anthony E. Lang,Yi Wen Tay,Marie Vidailhet,Emmanuel Roze,Joel S. Perlmutter,Jeanne S. Feuerstein,Victor S. C. Fung,Florence Chang,Richard L. Barbano,Steven Bellows,Aparna A. Wagle Shukla,Alberto J. Espay,Mark S. LeDoux,Brian D. Berman,Stephen Reich,Andres Deik,Andre Franke,Michael Wittig,Sören Franzenburg,Jens Volkmann,Norbert Brüggemann,H. A. Jinnah,Tobias Bäumer,Christine Klein,Hauke Busch,Katja Lohmann

Abstract:Dystonia is one of the most prevalent movement disorders, characterized by significant clinical and etiological heterogeneity. Despite considerable heritability (∼25%) and the identification of several disease-linked genes, the etiology in most patients remains elusive. Moreover, understanding the correlations between clinical manifestation and genetic variants has become increasingly complex. To comprehensively unravel dystonia’s genetic spectrum, we performed exome sequencing on 1,924 dystonia patients [40.3% male, 92.9% White, 93.2% isolated dystonia, median age at onset (AAO) 33 years], including 1,895 index patients, who were previously genetically unsolved. The sample was mainly based on two dystonia registries (DysTract and the Dystonia Coalition). Further, 72 additional patients of Asian ethnicity, mainly from Malaysia, were also included. We prioritized patients with negative genetic prescreening, early AAO, positive family history, and multisite involvement of dystonia. Rare variants in genes previously linked to dystonia ( =405) were examined. Variants were confirmed via Sanger sequencing, and segregation analysis was performed when possible. We identified 137 distinct likely pathogenic or pathogenic variants (according to ACMG criteria) across 51 genes in 163/1,924 patients [42.9% male, 85.9% White, 68.7% isolated dystonia, median AAO 19 years]. This included 153/1,895 index patients, resulting in a diagnostic yield of 8.1%. Notably, 77/137 (56.2%) of these variants were novel, with recurrent variants in , , , and , and novel variant types such as two splice site variants in , supported by functional evidence. Additionally, 321 index patients (16.9%) harbored variants of uncertain significance in 102 genes. The most frequently implicated genes included , , , , , and Presumably pathogenic variants in less well-established dystonia genes were also found, including , , and At least six variants (in , , , , and ) occurred supporting pathogenicity. ROC curve analysis indicated that AAO and the presence of generalized dystonia were the strongest predictors of a genetic diagnosis, with diagnostic yields of 28.6% in patients with generalized dystonia and 20.4% in those with AAO < 30 years. This study provides a comprehensive examination of the genetic landscape of dystonia, revealing valuable insights into the frequency of dystonia-linked genes and their associated phenotypes. It underscores the utility of exome sequencing in establishing diagnoses within this heterogeneous condition. Despite prescreening, presumably pathogenic variants were identified in almost 10% of patients. Our findings reaffirm several dystonia candidate genes and expand the phenotypic spectrum of some of these genes to include prominent, sometimes isolated dystonia.

Mutations in the gene encoding ɛ-sarcoglycan cause myoclonus–dystonia syndrome

Novel chloride channel gene mutations in two unrelated Chinese families with myotonia congenita.

Analysis of Clinical Phenotype and CGH1 Gene Mutations in a Family Affected with Dopa-Responsive Dystonia

Mutation in ε-Sarcoglycan Induces a Myoclonus-Dystonia Syndrome-Like Movement Disorder in Mice

Large‐Scale Screening: Phenotypic and Mutational Spectrum in Isolated and Combined Dystonia Genes

Deciphering the Pathophysiological Mechanisms Underpinning Myoclonus Dystonia Using Pluripotent Stem Cell-Derived Cellular Models

Loss‐of‐Function Variants in HOPS Complex Genes VPS16 and VPS41 Cause Early Onset Dystonia Associated with Lysosomal Abnormalities

Genetic Diversity and Expanded Phenotypes in Dystonia: Insights from Large-Scale Exome Sequencing

Gene-environment interaction elicits dystonia-like features and impaired translational regulation in a DYT-TOR1A mouse model

[Clinical and Genetic Analysis of Childhood-Onset Myoclonus Dystonia Syndrome Caused by SGCE Variants].

Intronic Pentanucleotide TTTCA Repeat Insertion in the SAMD12 Gene Causes Familial Cortical Myoclonic Tremor with Epilepsy Type 1

Dystonia genes and their biological pathways

Clinical and Genetic Spectrum of Sarcoglycanopathies in a Large Cohort of Chinese Patients.

Microstructure of the cerebellum and its afferent pathways underpins dystonia in myoclonus dystonia

KMT2B Is Selectively Required for Neuronal Transdifferentiation, and Its Loss Exposes Dystonia Candidate Genes

Panorama of the distal myopathies

Research Progress and Diagnostic Strategy of Genetic Pathogenesis of Dystonia

Untethering the Nuclear Envelope and Cytoskeleton: Biologically Distinct Dystonias Arising from a Common Cellular Dysfunction

Genetic Update and Treatment for Dystonia

Just Expect It: Compound Heterozygous Variants of POMT1 in a Consanguineous Family—The Role of Next Generation Sequencing in Neuromuscular Disorders

Behavioral and Electrophysiological Characterization of Dyt1 Heterozygous Knockout Mice